Pouneh studied Business Administration at the European Business School and speaks French, German and Farsi. She brings a wealth of investment and fund management experience, having spent much of her career in a number of senior roles with leading banks. As Co-Head of European Equities at MUFG, she managed a range of equity funds totalling £2bn, including a multi-award winning top performing unit trust. More recently, she ran a global research programme for HSBC’s head office corporate strategy function aimed at using key customer insights to develop better retirement products. As a member of Pynk’s Investment Committee, she is excited to utilise her lifelong passion for investing to help unearth great investment opportunities and also to bridge the gap between the Investment Committee and the valuable insights from Pynk’s amazing community. She has always been a strong believer in social impact, currently holding a number of charity board positions and is excited about the prospects of being involved in bringing about positive change as Pynk grows.
This week we are looking at Open Orphan, a potential game-changer for bringing vaccines to market in a much more efficient way. We see substantial shareholder returns as earnings upgrades materialise.
Pynk One Ltd is a company registered in England and Wales (No. 12940786) with registered office at 20-22 Wenlock Road, London, England, N1 7GU. Pynk One Ltd (FCA reference no. 942958) is an appointed representative of WealthKernel Limited (FCA reg no. 723719), which is authorised and regulated by the Financial Conduct Authority.
Investing involves risk to your capital. Past performance is not an indication of future results; the value of your investments can go down as well as up, and you may get back less than you originally invested. The information contained herein does not constitute investment advice or investment research and should not be relied upon to make any investment decisions. References to specific assets or securities are included for illustrative purposes and should not be understood as an endorsement or a recommendation to engage in investment activities. Please invest aware.